ANI Pharmaceuticals

$30.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.03 (+3.49%) As of 7:41 PM UTC today

Why Robinhood?

You can buy or sell ANIP and other stocks, options, and ETFs commission-free!

About ANIP

ANI Pharmaceuticals, Inc., also called ANI Pharmaceuticals, is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN. The listed name for ANIP is ANI Pharmaceuticals, Inc.

CEO
Nikhil Lalwani
Employees
338
Headquarters
Baudette, Minnesota
Founded
1996
Market Cap
388.33M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
54.82K
High Today
$30.53
Low Today
$29.31
Open Price
$29.89
Volume
29.37K
52 Week High
$52.22
52 Week Low
$23.55

ANIP News

Benzinga4h

ANI Pharmaceuticals's Earnings: A Preview

ANI Pharmaceuticals (NASDAQ:ANIP) announces its next round of earnings this Tuesday, March 09. Here is Benzinga's everything-that-matters guide for this Tuesday

ANIP Earnings

$0.00
$0.48
$0.96
$1.44
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
$0.94 per share
Actual
Available Mar 9, Pre-Market
Preview Earnings Call

You May Also Like

MIME
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure